NDC codes

FDA NDC Directory
Product NDC (as listed)0032-1206Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00032-1206Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0032-1206-01000321206011 BOTTLE in 1 CARTON (0032-1206-01) / 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLEMarketed from Apr 30, 2009
0032-1206-0700032120607250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1206-07)Marketed from Apr 30, 2009
0032-1206-56000321206561 BOTTLE in 1 CARTON (0032-1206-56) / 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLEMarketed from Apr 30, 2009 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Creon
Generic name (nonproprietary)
pancrelipase
Active ingredients
Pancrelipase amylase — 30000 [USP'U]/1Pancrelipase lipase — 6000 [USP'U]/1Pancrelipase protease — 19000 [USP'U]/1
Dosage form
Capsule, Delayed release pellets
Route
Oral
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 020725
Marketing start
Listing expires
Identifiers
Product ID 0032-1206_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87SPL ID a43ddd93-7d01-4bb9-95e3-b0629fe8ac87SPL set ID 073201aa-556d-4a70-918e-84e9616fd88dRxCUI 855495, 855499, 855503, 863829, 863836, 863841, 1113042, 1113046, 1373325, 1373327UNII YOJ58O116E, 3560D81V50, 8MYC33932OUPC 0300322637701, 0300320045706, 0300320047700, 0300320046703, 0300323016130, 0300322636704, 0300321212077, 0300321224018

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400032120601 followed by a unit qualifier and the quantity

Package 00032-1206-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

CREON ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. CREON is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under BLA 020725

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 020725
ProductStrengthForm · routeLabelerProduct NDC
CreonpancrelipasePancrelipase amylase 15000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed releaseOralAbbVie Inc.0032-1203
CreonpancrelipasePancrelipase amylase 30000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-0046
CreonpancrelipasePancrelipase lipase 36000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-2637
CreonpancrelipasePancrelipase lipase 24000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-1224
CreonpancrelipasePancrelipase amylase 60000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-0047
CreonpancrelipasePancrelipase lipase 36000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-3016
CreonpancrelipasePancrelipase amylase 15000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed releaseOralAbbVie Inc.0032-0045
CreonpancrelipasePancrelipase lipase 24000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-2636
CreonpancrelipasePancrelipase amylase 60000 [USP'U]/1 + 2 more ingredientsCapsule, Delayed release pelletsOralAbbVie Inc.0032-1212

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Creon (pancrelipase) NDC 0032-1206 | Med-Code